Novo goes after pharmacies compounding semaglutide

Danish pharma giant declares some compounded versions up to one-third impure The manufacturer of diabetes and weight-loss drugs Ozempic and Wegovy has taken legal action against two compounding pharmacies, accusing their products of being less potent than advertised and of containing impurities. The legal action by Novo Nordisk was instigated in Florida against compounders Wells